Covance Honored with Frost & Sullivan Asia Pacific Award for Fifth Consecutive Year

Awarded CRO 2018 Customer Value Leadership Award

BURLINGTON, N.C.–(BUSINESS WIRE)–Dec. 6, 2018–
LabCorp® (NYSE: LH), a leading global life sciences company, today
announced that its Covance Drug Development business (Covance) has been
awarded the 2018 Frost & Sullivan Asia Pacific CRO Customer Value
Leadership Award. The award reflects Covance’s continued commitment to
its Asia Pacific customers, with investments in deep scientific and
therapeutic expertise, and the most comprehensive drug and device
development capabilities.

This press release features multimedia. View the full release here:
https://www.businesswir…

Original Source